Why is "Carbamoyl phosphate" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-05-28 12:41:28
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Carbamoyl_phosphate entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-05-28 and was most recently seen on 2026-05-28.
Wikipedia Overview
Carbamoyl phosphate is an anion of biochemical significance. In land-dwelling animals, it is an intermediary metabolite in nitrogen disposal through the urea cycle and the synthesis of pyrimidines. Its enzymatic counterpart, carbamoyl phosphate synthetase I, interacts with a class of molecules called sirtuins, NAD dependent protein deacetylases, and ATP to form carbamoyl phosphate. CP then enters the urea cycle in which it reacts with ornithine to form citrulline.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Carbamoyl phosphate and its substitutes for the uracil synthesis in origins of life scenarios - Nature
-
Teaching NeuroImages: MRI findings in carbamoyl phosphate synthetase 1 deficiency - Neurology® Journals
-
Hyperammonemia in a carbamoyl-phosphate synthetase 1 deficiency recipient after living-donor liver transplantation from a carrier donor: a case report - Frontiers
-
World's First Patient Treated with Personalized CRISPR Gene Editing Therapy at Children’s Hospital of Philadelphia - Children's Hospital of Philadelphia
-
Breaking: First personalised mRNA CRISPR therapy delivered in six months - CRISPR Medicine News
-
Mechanism of thermal decomposition of carbamoyl phosphate and its stabilization by aspartate and ornithine transcarbamoylases - PNAS
-
Mary Ellen Jones: A Woman of Many Firsts - UNC Health
-
In a First, CRISPR Used to Treat Infant With Ultra-Rare Disease - MedPage Today
-
Neonatal Pulmonary Hypertension | NEJM - The New England Journal of Medicine
-
Structure of human carbamoyl phosphate synthetase: deciphering the on/off switch of human ureagenesis - Nature
-
Treating CPS1 Deficiency With Personalized Gene Editing - CGTLive®
-
Personalized gene editing corrects fatal infant metabolic disorder in world-first treatment - News-Medical
-
A Carbamoyl Phosphate Synthetase II (CPSII) Deletion Mutant of Toxoplasma gondii Induces Partial Protective Immunity in Mice - Frontiers
-
Infant becomes world's first patient to undergo personalized gene-editing treatment - CBS News
-
From Lab to Life: CRISPR's Advancements in Personalized Therapies for Metabolic, Blood, and Other Disorders - ISAAA.org
-
Plasmodium sporozoite phospholipid scramblase interacts with mammalian carbamoyl-phosphate synthetase 1 to infect hepatocytes - Nature
-
Infant is World's First Patient Treated with Customized CRISPR Gene Editing Therapy - ISAAA.org
-
Association between the p.Thr1406Asn polymorphism of the carbamoyl-phosphate synthetase 1 gene and necrotizing enterocolitis: A prospective multicenter study | Scientific Reports - Nature
-
Molecular and clinical analyses of Japanese patients with carbamoylphosphate synthetase 1 (CPS1) deficiency - Nature
-
The antigen for Hep Par 1 antibody is the urea cycle enzyme carbamoyl phosphate synthetase 1 - Nature
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.